HOME >> MEDICINE >> NEWS
Alcohol and drug treatment among HMO patients

  • Many alcohol and drug treatment programs have been merged since the early 1990s.
  • Yet a study has found that alcohol-only and alcohol-and-other-drug dependent clients appear to have different treatment needs and risk factors for developing drug-related problems.
  • Those with an alcohol-and-other-drug dependency were more likely to be younger, male, less educated, African American, and have greater psychiatric and family/social problems.
  • Those with an alcohol-only dependency were much more likely to be older, female, Caucasian, and college educated than those individuals with a combined dependency.
Until approximately a decade ago, alcohol and drug treatment programs in the United States were separate. Each type of program had its own patients, policies and methods of treatment. Yet many individuals who were dependent on alcohol also used, and were often dependent on, other drugs. This might explain why numerous alcohol and drug treatment programs were merged in the early 1990s. The effectiveness of these combined treatment programs, however, remains unclear. A study in the December issue of Alcoholism: Clinical & Experimental Research is one of the first to attempt to understand how the needs and problems of alcohol and drug patients may differ even though they are now usually treated in the same program.

Researchers interviewed more than 700 people seeking treatment in a program operated by their health maintenance organization (HMO). Clients were divided into two samples: those who were dependent only on alcohol (491 or 69%) and those who were dependent on both alcohol and other drugs (217 or 31%). The objectives were to identify both treatment needs as well as risk factors for developing substance abuse-related problems among the two types of clients.

"The two groups of clients in this HMO treatment population can be distinguished by demographic characteristics," explained Tammy Tam, a scientist with the Alcohol R
'"/>

Contact: Tammy W. Tam, Ph.D.
ttam@arg.org
510-642-0584
Alcoholism: Clinical & Experimental Research
13-Dec-2000


Page: 1 2 3 4

Related medicine news :

1. Alcohol relapse adversely affects 10-year liver transplant survival
2. Alcohol intervention attempted for violent males
3. Alcohols damaging effects on adolescent brain function
4. Alcohol drinkers three times as likely to die from injury
5. Alcohol: Global burden on health similar to tobacco and high blood pressure
6. Alcoholics can have deficits in visuoperception and frontal executive function despite sobriety
7. RFA safe for treating liver tumors pushing on GI tract; Alcohol injection makes RFA more effective
8. Alcohol consumption may be associated with irregular heart beat in men
9. Alcohol use and victimization among college women
10. Alcohol limit for drink driving should be much lower
11. Alcohol-related emergency department visits higher than previously thought

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Alcohol and drug treatment among HMO patients

(Date:5/19/2013)... 2013 These molecular diagnostics market ... Spain, Japan, Italy, Germany and France:, ... laboratory practice, as well as key economic, regulatory, ... impact during the next five years. , ... technologies, test formats, detection methodologies, trends in testing ...
(Date:5/19/2013)... May 19, 2013 Americans live closer ... the newest American Veterinary Medical Association (AVMA) U.S. Pet ... dog owners consider their dog a member of the ... said as much five years earlier. , According to ... of the national income dedicated to pets has increased ...
(Date:5/19/2013)... Vegas Hotel Escapes, the premier Las ... launch it's all new vacation packages for the upcoming ... Consumers traveling to Las Vegas will be pleased to ... website. Travelers will be pleased to know that VegasHotelEscapes.com ... Vegas Hotel Escapes specializes in helping consumers Las ...
(Date:5/19/2013)... Passages Malibu, the leading non-12 step, holistic, and ... the launch of a “Sobriety, Health, and Wellness” survey ... “We are always looking for new ways to engage ... regarding sobriety, what’s working for people, and what isn’t,” ... Passages Addiction Treatment Centers located in Malibu and ...
(Date:5/19/2013)... HealthEconomics.Com , the global leader ... unveil a new and exciting service: HE-Xpo: a media-rich, ... array of real-time communication tools to expand their digital ... , HE-Xpo is powered by OnStream Media’s ... feel of being at a physical trade show, all ...
Breaking Medicine News(10 mins):Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 2Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 3Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 4Health News:Dogs Becoming Part of the Family: Dog Bite Injuries Decreasing 2Health News:Dogs Becoming Part of the Family: Dog Bite Injuries Decreasing 3Health News:Passages Malibu Announces its Sobriety, Health, and Wellness Social Media Survey 2Health News:Passages Malibu Announces its Sobriety, Health, and Wellness Social Media Survey 3Health News:HealthEconomics.Com Announces HE-Xpo, a New Virtual Trade Show Devoted to Healthcare Value and Market Access 2Health News:HealthEconomics.Com Announces HE-Xpo, a New Virtual Trade Show Devoted to Healthcare Value and Market Access 3
(Date:5/17/2013)... May 17, 2013  Boehringer Ingelheim will contribute ... at the American Thoracic Society International Conference (ATS ... May 17 – 22. Data will ... the treatment of chronic obstructive pulmonary disease (COPD) ... as investigational compounds for asthma, idiopathic pulmonary fibrosis ...
(Date:5/17/2013)... PARIS , May 17, 2013  Sanofi (EURONEXT: ... the pivotal study, JAKARTA , examining ... its primary endpoint in both dose groups. The primary ... of spleen volume. Consistent with data reported in previous ... nausea and vomiting. Full results will be presented at ...
(Date:5/17/2013)...  Boston Scientific Corporation (NYSE: BSX ) ... Program May 21-24 in Paris . ... rich and diversified set of data this year at ... global chief medical officer, Boston Scientific.  "The primary endpoint ... NG PROMUS trial, which evaluated our Promus PREMIER ™ ...
Breaking Medicine Technology:Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 2Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 3Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 4Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 5Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 6Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 7Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 8Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 2Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 3Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 4Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 5Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 6Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 2Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 3Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 4Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 5Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 6Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 7Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 8
Cached News: